findmyKOL
Clinical trialNCT06921603RecruitingInterventional

POCUS-Guided Diuresis for Decompensated Heart Failure

SponsorUniversity of PittsburghEnrollment588Acute Kidney InjuriesHeart Decompensation, Acute
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Heart failure occurs when the heart cannot pump blood effectively, leading to fluid buildup in the body. This can cause problems such as difficulty breathing, swelling, and extreme tiredness. In severe cases, these symptoms worsen to the point where hospitalization is required. Unfortunately, many patients with severe heart failure are readmitted to the hospital within 30 days after discharge, which is both physically and emotionally challenging for patients and places a significant financial burden on individuals and the healthcare system. Although symptoms such as difficulty breathing and swelling may improve during the hospital stay, some patients are discharged with excess fluid remaining in their bodies. This retained fluid often causes symptoms to worsen, leading to subsequent hospital readmissions. Inadequate management of fluid levels can also harm the kidneys, further complicating the patient's condition. This study aims to improve care for heart failure patients by utilizing a simple, non-invasive tool to assess fluid levels more accurately at the bedside. The tool measures the size of a large blood vessel in the neck, providing key information about the pressure inside the heart. This information enables clinicians to determine the appropriate amount of medication needed to remove just the right amount of fluid. Properly managing fluid levels can help prevent kidney damage and improve overall patient outcomes. The primary goal of this study is to evaluate whether this tool can reduce the number of patients readmitted to the hospital within 30 days of discharge. A secondary goal is to determine whether the tool can help protect kidney function by allowing for better fluid management. If successful, this approach has the potential to help heart failure patients stay healthier, reduce hospital visits, and lower healthcare costs.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Upmc East

    Pittsburgh, Pennsylvania, United States

    Hamit Mahamat Chahata, MD
    Not, yet, recruiting
  • Upmc Mercy

    Pittsburgh, Pennsylvania, United States

    Vanessa Mutch, MD
    Not, yet, recruiting
  • Upmc Presbyterian

    Pittsburgh, Pennsylvania, United States

    Benay Ozbay, MD
    Recruiting
  • Upmc Shadyside

    Pittsburgh, Pennsylvania, United States

    Adam Sohnen, MDJames Ma, MD
    Recruiting
  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, United States

    Benay Ozbay, MDJohn Pacella, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Jun 2025
Primary completion
31 Dec 2026
Completion
31 Dec 2026
Last update posted
17 Feb 2026
Registered enrollment
588
Registry id
NCT06921603

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.